A recent clinical trial reveals that Wegovy, a popular weight-loss drug containing semaglutide, shows promising results in treating liver diseases like MASH. The study, published in the New England Journal of Medicine, involved over 800 participants across 37 countries. Wegovy significantly reduced liver inflammation and scarring, offering hope for millions affected by fatty liver diseases.from LifeStyle - Latest Lifestyle News, Hot Trends, Celebrity Styles & Events https://ift.tt/vCf2arh
https://ift.tt/teisfyn
Related Post
10 tiny habits to train your brain for a more peaceful lifeMost people live a fast-paced and chaotic life, where peace seems like a distant dream. If you too - Can this creamy green fruit help you sleep? Scientists think so!Avocados, known for their creamy texture and healthy fats, may surprisingly aid sleep. Rich in magn
- Why is kidney failure called the silent killer?Kidney failure, a silent killer, often goes unnoticed as the body adapts, masking symptoms like fat
- BTS' V goes bare-faced liveBTS' V goes bare-faced live: Kim Taehyung flexes muscles, changes outfits, plays music and Counter-
:)
:(
=(
^_^
:D
=D
=)D
|o|
@@,
;)
:-bd
:-d
:p
:ng